Arthritis News and Research

Latest Arthritis News and Research

Clinical and demographic inequalities in COVID-19-associated mortality

Researchers quantified the relative and absolute changes in COVID-19-related mortality based on clinical and demographical profiles of 18 million adult patients throughout the pandemic in England.

4 Aug 2022

Integrated community care approach can offer solution to struggling rheumatology services, experts say

As patients wait up to a decade for the diagnosis of life-impacting rheumatic conditions, experts argue that ingrained pressures facing NHS rheumatology services can, and should, be eased with an integrated community care/secondary care approach, rather than a reliance on secondary care alone.

3 Aug 2022

Gout flares associated with subsequent cardiovascular events

Experts at the University of Nottingham, in collaboration with experts at Keele University, have found that the risk of heart attacks and strokes temporarily increases in the four months after a gout flare.

2 Aug 2022

New treatment gives hope for people challenged with chronic back pain

People challenged with chronic back pain have been given hope with a new treatment that focuses on retraining how the back and the brain communicate, a randomized controlled trial run by researchers at UNSW Sydney and Neuroscience Research Australia and several other Australian and European universities has shown.

2 Aug 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

UT Southwestern physicians outline the risks of pregnancy in women with rheumatic disease

Pregnant women with active rheumatic disease carry a higher risk of adverse outcomes than the general population including hypertension, preeclampsia, higher cesarean section rate, small for gestational aged infants, preterm delivery, and fetal loss. To

19 Jul 2022

The impact of glucocorticoid therapy on immune responses to COVID-19 vaccination or infection in rituximab-treated patients with autoimmune disorders

Researchers examined immune reactions to SARS-CoV-2)among B cell-depleted autoimmune patients who concomitantly administered glucocorticoids.

18 Jul 2022

Alcohol consumption does not provide any health benefits, presents many risks for young people

Young people face higher health risks from alcohol consumption than older adults, according to a new analysis published in The Lancet.

15 Jul 2022

Study describes biochemical pathway that leads to inflammation characteristic of autoimmune diseases

Mitochondria are self-contained organelles (they possess their own mini-chromosome and DNA) residing within cells and are charged with the job of generating the chemical energy needed to fuel functions essential to life and well-being.

13 Jul 2022

Researchers create a comprehensive map of how complex networks of genes function together

Using new technologies to study thousands of genes simultaneously within immune cells, researchers at Gladstone Institutes, UC San Francisco (UCSF), and Stanford School of Medicine have created the most detailed map yet of how complex networks of genes function together.

11 Jul 2022

The interplay of family history and genome-wide polygenic risk scores across 24 common diseases

A new study has investigated the interplay of FH and genome-wide PRS

11 Jul 2022

Study sheds light on cell type-specific biomarkers of melanoma

A new UC Davis-led study sheds light on cell type-specific biomarkers, or signs, of melanoma. The research was recently published in the Journal of Investigative Dermatology.

10 Jul 2022

Childhood physical abuse victims more likely to experience poor physical and mental health

Older adults who were physically abused as children were significantly more likely to develop chronic pain and chronic physical illness in later life according to a newly-released study by University of Toronto researchers.

7 Jul 2022

Low doses of a less commonly used drug may be a better treatment option for gout

Gout occurs when urate crystals accumulate in the joints, and xanthine oxidase inhibitors such as febuxostat are a mainstay of therapy to help reduce blood urate levels in affected patients.

7 Jul 2022

Scientists discover a key starting point for inhibiting inflammation in psoriasis and psoriatic arthritis

Around 250,000 people in Austria suffer from psoriasis. One third of them develop inflammation in their joints (psoriatic arthritis) as a result of the chronic skin condition.

6 Jul 2022

Study results underscore the challenges in treating interstitial pneumonia with autoimmune features

Interstitial pneumonia with autoimmune features (IPAF) is a disease with many possible causes and no standard of care, making it particularly difficult to treat.

5 Jul 2022

How does obesity affect the immune system?

A new study summarizes new findings on the immunoregulatory effects of excessive fat stores or malnutrition through Th2 cells.

4 Jul 2022

Stopping a pervasive bacterium that makes millions sick each year

As we head outdoors this summer, scientists are working to clip the long, flexible appendages that enable the common bacterium Campylobacter jejuni to make its way from undercooked poultry and natural waterways into our intestinal tract where it makes millions of us sick each year.

1 Jul 2022

New machine learning method may improve the identification of genes that cause diseases

A new machine learning method to model gene expression levels might improve the identification of genes that cause human diseases, according to a new study by Penn State College of Medicine researchers.

28 Jun 2022

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

AbbVie today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of upadacitinib (RINVOQ® 15 mg, once daily) for the treatment of active non-radiographic axial spondyloarthritis (nr‑axSpA) in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs).*

27 Jun 2022

Arthritis News and Research

Latest Arthritis News and Research

Clinical and demographic inequalities in COVID-19-associated mortality

Integrated community care approach can offer solution to struggling rheumatology services, experts say

Gout flares associated with subsequent cardiovascular events

New treatment gives hope for people challenged with chronic back pain

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

UT Southwestern physicians outline the risks of pregnancy in women with rheumatic disease

The impact of glucocorticoid therapy on immune responses to COVID-19 vaccination or infection in rituximab-treated patients with autoimmune disorders

Alcohol consumption does not provide any health benefits, presents many risks for young people

Study describes biochemical pathway that leads to inflammation characteristic of autoimmune diseases

Researchers create a comprehensive map of how complex networks of genes function together

The interplay of family history and genome-wide polygenic risk scores across 24 common diseases

Study sheds light on cell type-specific biomarkers of melanoma

Childhood physical abuse victims more likely to experience poor physical and mental health

Low doses of a less commonly used drug may be a better treatment option for gout

Scientists discover a key starting point for inhibiting inflammation in psoriasis and psoriatic arthritis

Study results underscore the challenges in treating interstitial pneumonia with autoimmune features

How does obesity affect the immune system?

Stopping a pervasive bacterium that makes millions sick each year

New machine learning method may improve the identification of genes that cause diseases

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Arthritis News and Research

Latest Arthritis News and Research

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Newsletters you may be interested in